EIU Healthcare zooms in on two of the fastest-growing molecular testing areas: cancer and Covid-19 testing to uncover the market opportunities for IVD companies.
In this webinar, EIU Healthcare discusses our outlook on the molecular diagnostics (MDx) market, covering:
• Covid-19 impact: How has the Covid-19 pandemic impacted the global MDx market for instruments and test areas
• Laboratory insights: How is the molecular testing environment in Asia and Europe evolving?
• New players: What are some emerging players to watch and how will they shape up competition in the market?
• New technologies: How will the growing adoption of molecular testing impact the use of more traditional diagnostic technologies?
Watch webinar on-demand
Fill out the form to access the webinar recording.